Načítá se...
Patently unpatentable: implications of the Myriad court decision on genetic diagnostics
The recent decision in the case Association for Molecular Pathology et al. v. United States Patent and Trademark Office et al. shocked the biotechnology industry. Although the case could be overturned on appeal, it will likely change how gene patents are written. The effects of the decision may be m...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2955823/ https://ncbi.nlm.nih.gov/pubmed/20832881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tibtech.2010.08.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|